المؤلفون: Peters, Stephen P, Bleecker, Eugene R, Kunselman, Susan J, Icitovic, Nikolina, Moore, Wendy C, Pascual, Rodolfo, Ameredes, Bill T, Boushey, Homer A, Calhoun, William J, Castro, Mario, Cherniack, Reuben M, Craig, Timothy, Denlinger, Loren C, Engle, Linda L, Dimango, Emily A, Israel, Elliot, Kraft, Monica, Lazarus, Stephen C, Lemanske, Robert F, Lugogo, Njira, Martin, Richard J, Meyers, Deborah A, Ramsdell, Joe, Sorkness, Christine A, Sutherland, E Rand, Wasserman, Stephen I, Walter, Michael J, Wechsler, Michael E, Chinchilli, Vernon M, Szefler, Stanley J, National Heart, Lung, and Blood Institute's Asthma Clinical Research Network

المصدر: The Journal of allergy and clinical immunology. 132(5)

مصطلحات موضوعية: National Heart, Lung, and Blood Institute's Asthma Clinical Research Network, Humans, Asthma, Albuterol, Scopolamine Derivatives, Bronchodilator Agents, Anti-Asthmatic Agents, Prognosis, Treatment Outcome, Cross-Over Studies, Adult, Middle Aged, Female, Male, Adrenergic beta-2 Receptor Agonists, Tiotropium Bromide, Salmeterol Xinafoate, ACD, ACRN, Asthma Clinical Research Network, Asthma control day, FVC, Forced vital capacity, HFA, Hydrofluoroalkane, ICS, Inhaled corticosteroid, LABA, LAMA, Long-acting muscarinic antagonist, Long-acting β-agonist, NHLBI, National Heart, Lung, and Blood Institute, OR, Odds ratio, PEF, Peak expiratory flow, TALC, Tiotropium Bromide as an Alternative to Increased Inhaled Glucocorticoid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (ClinicalTrials.gov number, NCT00565266) trial, predictor of response, responder analysis, salmeterol, tiotropium, Clinical Research, Lung, Respiratory, Immunology, Allergy

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/2xq3b78pTest

المؤلفون: Soheila Najafzadeh, Vanessa N. Barth, Yiyun Huang, Mika Naganawa, Nabeel Nabulsi, Antonio Navarro, Jim Ropchan, Ansel T. Hillmer, Richard E. Carson, Irina Esterlis, Kelly P. Cosgrove, Kelly Smart, Stephen R. Baldassarri, Hong Gao

المصدر: Cereb Cortex

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Indoles, Cognitive Neuroscience, Scopolamine, Striatum, Receptors, Nicotinic, Nicotine, Young Adult, 03 medical and health sciences, Cellular and Molecular Neuroscience, 0302 clinical medicine, Piperidines, Internal medicine, Muscarinic acetylcholine receptor, medicine, Animals, Humans, 030304 developmental biology, 0303 health sciences, Chemistry, Receptor, Muscarinic M1, Brain, Muscarinic antagonist, Human brain, Middle Aged, Macaca mulatta, Acetylcholine, Endocrinology, medicine.anatomical_structure, Nicotinic agonist, Positron-Emission Tomography, Cholinergic, Original Article, Female, Radiopharmaceuticals, 030217 neurology & neurosurgery, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b46068526441f43076729747252129eTest
https://doi.org/10.1093/cercor/bhaa387Test

المؤلفون: Makoto Yoshida, Atsushi Kawaguchi, Naoko Sueoka-Aragane, Ayako Takamori, Shinichiro Hayashi, Hiroki Tashiro, Takashi Kinoshita, Hiroshi Inoue, Keisuke Kojima, Ryo Tajiri, Koichiro Takahashi, Go Kato, Tomotaka Kawayama, Masahide Tanaka, Shinya Kimura, Hiromi Kobayashi, Masaru Uchida, Hironori Sadamatsu

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Spirometry, Male, medicine.medical_specialty, medicine.drug_class, Physical activity, physical activity, Metabolic equivalent, chronic obstructive pulmonary disease, 03 medical and health sciences, chemistry.chemical_compound, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Bronchodilator, Internal medicine, Forced Expiratory Volume, medicine, Humans, long-acting muscarinic antagonist, In patient, 030212 general & internal medicine, Prospective Studies, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Exercise, Lung, Aged, Original Research, COPD, medicine.diagnostic_test, business.industry, Olodaterol, General Medicine, Middle Aged, medicine.disease, Benzoxazines, Bronchodilator Agents, respiratory tract diseases, Drug Combinations, Treatment Outcome, 030228 respiratory system, chemistry, Cardiology, Female, long-acting beta 2 agonist, business, Body mass index, human activities

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25992fa836e3ce7f10cca83afc16dd00Test
http://europepmc.org/articles/PMC7501469Test

المؤلفون: Gary T. Ferguson, David A. Lipson, Kelly Dorais, Frank C. Sciurba, Thomas C. Corbridge, Catherine Harvey, Neil R.W. Martin, David I. Bernstein, Marjorie Stiegler, Charles Fogarty, Chang-Qing Zhu, Nicola Brown, Morrys C. Kaisermann, Chris Compton

المصدر: Respiratory Research, Vol 21, Iss 1, Pp 1-15 (2020)
Respiratory Research

مصطلحات موضوعية: Male, Budesonide, Health Status, law.invention, Pulmonary Disease, Chronic Obstructive, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Budesonide, Formoterol Fumarate Drug Combination, 030212 general & internal medicine, Lung, education.field_of_study, COPD, Middle Aged, Bronchodilator Agents, Treatment Outcome, Long-acting muscarinic antagonist (LAMA), Inhaled corticosteroid (ICS), Female, Vilanterol, medicine.drug, medicine.medical_specialty, Population, Drug Administration Schedule, Fluticasone propionate, 03 medical and health sciences, Double-Blind Method, Long-acting β2-agonist (LABA), Internal medicine, Administration, Inhalation, medicine, Humans, education, Triple therapy, Aged, lcsh:RC705-779, business.industry, Research, Nebulizers and Vaporizers, Inhaler, lcsh:Diseases of the respiratory system, medicine.disease, Lung function, Androstadienes, 030228 respiratory system, chemistry, Symptoms, Formoterol, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdf5859830c5c812e4b0c6afa48117cdTest
http://link.springer.com/article/10.1186/s12931-020-01360-wTest

المؤلفون: Colin Reisner, Klaus F. Rabe, Martin Jenkins, Brian Lipworth, Ubaldo J. Martin, Fernando J. Martinez, Samir Arora

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, Exacerbation, bronchodilator, muscarinic antagonist, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Formoterol Fumarate, Bronchodilator, β2- agonist, Multicenter Studies as Topic, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, education.field_of_study, COPD, integumentary system, co-suspension delivery technology, General Medicine, Middle Aged, Metered-dose inhaler, Obstructive lung disease, Bronchodilator Agents, Drug Combinations, Treatment Outcome, Female, medicine.medical_specialty, medicine.drug_class, Population, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, 03 medical and health sciences, Internal medicine, Administration, Inhalation, medicine, Humans, Metered Dose Inhalers, education, Adrenergic beta-2 Receptor Agonists, Aged, business.industry, lung function, Recovery of Function, medicine.disease, Glycopyrrolate, Clinical Trials, Phase III as Topic, 030228 respiratory system, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::168165fcd6c39542bd6a0b409b60d3ecTest
https://doi.org/10.2147/copd.s229794Test

المؤلفون: Eric Bourne, Gary T. Ferguson, Yoshikazu Inoue, Kiernan DeAngelis, Hiroshi Okada, Nobuya Hayashi, Masakazu Ichinose, Osamu Hataji, Klaus F. Rabe, Shaila Ballal, Paul Dorinsky, Magnus Aurivillius, Yasushi Fukushima, Colin Reisner, Mami Takikawa

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Budesonide, Male, medicine.medical_specialty, Population, International Journal of Chronic Obstructive Pulmonary Disease, inhaled corticosteroid, Severity of Illness Index, Time, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Japan, Double-Blind Method, Internal medicine, Formoterol Fumarate, medicine, long-acting muscarinic antagonist, Humans, 030212 general & internal medicine, Metered Dose Inhalers, long-acting β2-agonist, education, Original Research, COPD, education.field_of_study, integumentary system, business.industry, co-suspension delivery technology, ICS/LAMA/LABA, General Medicine, Drug Tolerance, Middle Aged, medicine.disease, Metered-dose inhaler, Glycopyrrolate, Dry-powder inhaler, Bronchodilator Agents, Respiratory Function Tests, Drug Combinations, Treatment Outcome, 030228 respiratory system, Tolerability, Bronchitis, Female, Drug Monitoring, business, medicine.drug

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cebea17bf9328c5d1ee322ed65c26717Test
http://europepmc.org/articles/PMC6934178Test

المؤلفون: Shuchita Kaila, Mary DuCharme, Swetha R Palli, Ami R Buikema, Monica Frazer, Timothy Juday

المصدر: Journal of Comparative Effectiveness Research. 8:1299-1316

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, medicine.drug_class, Pulmonary disease, Muscarinic Antagonists, Medicare, Inverse probability of treatment weighting, Insurance Claim Review, Pulmonary Disease, Chronic Obstructive, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Internal medicine, medicine, Humans, 030212 general & internal medicine, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Aged, Aged, 80 and over, COPD, business.industry, β2 agonists, Health Policy, Tiotropium-olodaterol, Muscarinic antagonist, Pneumonia, Middle Aged, medicine.disease, United States, Benzoxazines, Bronchodilator Agents, Drug Combinations, Models, Economic, Treatment Outcome, 030228 respiratory system, Disease Progression, Corticosteroid, Drug Therapy, Combination, Female, Health Expenditures, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::697ad907cac43d84a5f2294535f4433dTest
https://doi.org/10.2217/cer-2019-0101Test

المؤلفون: Borin, Marie T, Lo, Arthur, Barnes, Chris N, Pendyala, Srikanth, Bourdet, David L

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Adolescent, kidney disease, LAMA, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Middle Aged, Severity of Illness Index, chronic obstructive pulmonary disease, revefenacin, Young Adult, Benzamides, long-acting muscarinic antagonist, Hepatic Insufficiency, Humans, Multicenter Studies as Topic, Female, Carbamates, Renal Insufficiency, liver disease, Original Research, Aged

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::87dc60caf06b3dc1796793d05e9993b6Test
http://europepmc.org/articles/PMC6790214Test

المؤلفون: Glenn Crater, Brett Haumann, Chris N. Barnes, Edward Kerwin, James F. Donohue, Edmund J. Moran

المصدر: BMC Pulmonary Medicine
BMC Pulmonary Medicine, Vol 20, Iss 1, Pp 1-10 (2020)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Male, medicine.medical_specialty, Time Factors, Efficacy, Population, Revefenacin, Subgroup analysis, Muscarinic Antagonists, Placebo, Severity of Illness Index, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Internal medicine, Forced Expiratory Volume, Administration, Inhalation, Nebulized therapy, Medicine, Humans, COPD, 030212 general & internal medicine, education, Lung, Aged, lcsh:RC705-779, Aged, 80 and over, education.field_of_study, Dose-Response Relationship, Drug, business.industry, Muscarinic antagonist, lcsh:Diseases of the respiratory system, Middle Aged, medicine.disease, Comorbidity, Bronchodilator Agents, respiratory tract diseases, Clinical trial, Long-acting muscarinic antagonist, 030228 respiratory system, Benzamides, Female, Carbamates, business, medicine.drug, Research Article

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89d049d668cd42708b5cdfda2ec16138Test
https://doi.org/10.21203/rs.3.rs-15871/v1Test

المؤلفون: Dean Quinn, David L. Bourdet, Dave Singh, Edmund J. Moran, Peter Potgieter, Wayne Yates, Andrew Nicholls, Brett Haumann, Chris N. Barnes

المصدر: Quinn, D, Barnes, C N, Yates, W, Bourdet, D L, Moran, E J, Potgieter, P, Nicholls, A, Haumann, B & Singh, D 2018, ' Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD) : Results of two randomized, double-blind, phase 2 studies ', Pulmonary Pharmacology and Therapeutics, vol. 48, pp. 71-79 . https://doi.org/10.1016/j.pupt.2017.10.003Test

مصطلحات موضوعية: Male, Time Factors, Revefenacin, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Bronchodilator, Once-daily, Pharmacology (medical), 030212 general & internal medicine, COPD, Cross-Over Studies, Ipratropium, Middle Aged, Bronchodilator Agents, Anti-muscarinic, Inhalation, Anesthesia, Benzamides, Female, medicine.drug, Pulmonary and Respiratory Medicine, medicine.drug_class, Rapid onset, Muscarinic Antagonists, Placebo, 03 medical and health sciences, Double-Blind Method, Pharmacokinetics, Administration, Inhalation, medicine, Humans, Aged, Biochemistry, medical, business.industry, Nebulizers and Vaporizers, Biochemistry (medical), Muscarinic antagonist, medicine.disease, Crossover study, Long-acting muscarinic antagonist, 030228 respiratory system, Spirometry, Pharmacodynamics, Nebulized, Carbamates, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::508ec8e7267077e35456dbfaa535e283Test
https://doi.org/10.1016/j.pupt.2017.10.003Test